EFSA Compendium of Botanicals

Draft - work in progress

Tradescantia spathacea Sw.

Family:: Commelinaceae
Approval state:: Approved
Number of articles retrieved:: 38
Number of processed references:: 2

Compositions

Endpoint Studies

Genotoxicity

Composition #1: Vo, QH., Nguyen, PH., Zhao, BT., Ali, MY., Choi, JS., Min, BS., Nguyen, TH., Woo, MH. Protein tyrosine phosphatase 1B (PTP1B) inhibitory constituents from the aerial parts of Tradescantia spathacea Sw.. FITOTERAPIA, 2015, vol. 103, p. 113–121. DOI: 10.1016/j.fitote.2015.03.017. [DOI link]

Language:

English (en)
Plant part:

Aerial part of plants (as part-nature) (A166F)
Extraction/Preparation method:

Solvent extraction (A0BZR)
Additional extraction description:

99.8 % Methanol
Substance:

furan derivatives (RF-00004396-PAR)
Additional substance description:

(2R,3R)-2,3-dihydroxy-2-methylbutyrolactone; bracteanolide A; 4-(3′,4′-dihydroxyphenyl)furan-2(5H)-one
Analytical method code:

Chromatographic tests (F015A)
Analytical method - additional description:

NMR
Yes/No Qualitative:

Positive/Present (POS)
Result type:

Qualitative Value (Binary) (BIN)
Internal remarks:

Furan derivatives (aerial parts)

Endpoint study #1: de Capitani, Eduardo M., Cunha, Jessica S., Gattai, Silvia R. C., Borrasca-Fernandes, Carla F., Dutilh, Julie H. A. Toxic effects due to ingestion of Tradescantia spathacea (Sw.) leaves by an adult dog . clinical toxicology, 2015, vol. 53, no. 4, p. 271–272. .

Study relevance:

Animal (target species) health
Substance:

Calcium oxalate (RF-00003960-PAR)
Plant part:

Leaves (as part-nature) (A0EKT)
Preparation/Extraction method:

Fresh (A166Y)
Additional plant/substance description:

raphides and prismatic calcium oxalate
Type of toxicological test:

case report (CHD060TT)
Limit test:

Not applicable
Tested organism:

Dog (as animal) (A0CNL)
Sex:

Male
Route of exposure:

ORAL: UNSPECIFIED (OECD2234PL)
Number of organisms dosed:

1
Control groups used:

no
Endpoint measured:

Dose not reported (CHD066EP)
Critical effect:

Digestive (TOX18A)
Target tissue:

Digestive (TT002A)
Effect description:

tachycardia, tachypnea, abdominal pains, muscle tremors, hypersalivation
Effect or parameter linked to the endpoint:

behaviour (CHD001BE)
Internal remarks:

Case report dog, leaves